SN

Silvia Noiman

Founder of Imel Biotherapeutics

Israel

Overview

Work Experience

IB

Imel Biotherapeutics Inc

  • Founder, CEO & Board Member

    2019 - 2024

Sentaur Biosciences

  • Board Member

    2019 - 2024

KP

Kamari Pharma

  • Board Member

    2018 - 2023

PV

Pontifax Venture Capital

  • Venture partner, entrepreneur and executive

    2010 - 2023

VT

VICO Therapeutics B.V.

  • Board Member

    2019 - 2022

EP

Eloxx Pharmaceuticals

  • Founder, Board Member & CEO

    2013 - 2021

    http://www.eloxxpharma.com/

AT

ABAC Therapeutics

  • Board Member

    2018 - 2019

ProMining Therapeutics, LTD

  • Co-Founder & Executive Chairwoman

    2011 - 2015

Quiet Therapeutics

  • Co-Founder & Executive Chairwoman

    2010 - 2015

cCAM Biotherapeutics (aquired by Merck in July 2015)

  • Founder, Executive Chairwoman, Director

    2010 - 2015

Education

Investments

Vico Therapeutics

Series A

Total Funding: $120M

ABAC Therapeutics

Series A

Total Funding: $20M

Relevant Websites